Literature DB >> 27380528

Association of Heart Rate with N-Terminal Pro-B-Type Natriuretic Peptide in Septic Patients: A Prospective Observational Cohort Study.

Naoki Hayase1, Miyuki Yamamoto, Toshifumi Asada, Rei Isshiki, Naoki Yahagi, Kent Doi.   

Abstract

BACKGROUND: Excessive sympathetic stress has multiple adverse effects during critical illness including sepsis. Recent studies showed that heart rate control had a significant effect on reducing mortality in septic shock patients. Furthermore, elevated N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels in septic patients were reportedly associated with adverse outcome. However, no study has evaluated the relationship between hemodynamic profiles of septic patients and the circulating cardiac biomarker. Our objective was to determine whether hemodynamic profiles, specifically tachycardia and new-onset atrial fibrillation (AF), were associated with NT-proBNP elevation in septic patients.
METHODS: We consecutively enrolled patients admitted to our intensive care unit (ICU). NT-proBNP levels, heart rate, and rhythm at ICU admission were measured, and all clinical and laboratory data were prospectively collected. Tachycardia was defined as a heart rate of above 100 bpm.
RESULTS: Ninety-five patients out of 267 patients (35.6%) were diagnosed as sepsis. Of these septic patients, 47 presented with tachycardia and 6 developed new-onset AF. Multivariate Cox regression analysis revealed that tachycardia was an independent predictor of 28-day overall survival in septic patients (hazard ratio, 4.22; 95% confidence interval, 1.10-27.72; P < 0.05), but not in nonseptic patients. Multivariate linear regression analysis demonstrated that the presence of tachycardia was an independent determinant of NT-proBNP elevation (P < 0.05) in septic patients, but not in nonseptic patients.
CONCLUSIONS: Tachycardia was significantly and independently associated with NT-proBNP elevation and lower survival rate in septic patients, although no association was observed in nonseptic patients. Increased NT-proBNP in sepsis with tachycardia might predict poor outcomes in ICU.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27380528     DOI: 10.1097/SHK.0000000000000673

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  7 in total

Review 1.  Prevalence of New-Onset Atrial Fibrillation and Associated Outcomes in Patients with Sepsis: A Systematic Review and Meta-Analysis.

Authors:  Bernadette Corica; Giulio Francesco Romiti; Stefania Basili; Marco Proietti
Journal:  J Pers Med       Date:  2022-03-30

2.  Impact of patient characteristics on the efficacy and safety of landiolol in patients with sepsis-related tachyarrhythmia: Subanalysis of the J-Land 3S randomised controlled study.

Authors:  Naoyuki Matsuda; Osamu Nishida; Takumi Taniguchi; Masaki Okajima; Hiroshi Morimatsu; Hiroshi Ogura; Yoshitsugu Yamada; Tetsuji Nagano; Akira Ichikawa; Yasuyuki Kakihana
Journal:  EClinicalMedicine       Date:  2020-10-13

3.  Effects of low doses of esmolol on cardiac and vascular function in experimental septic shock.

Authors:  Chaojie Wei; Huguette Louis; Margaux Schmitt; Eliane Albuisson; Sophie Orlowski; Bruno Levy; Antoine Kimmoun
Journal:  Crit Care       Date:  2016-12-21       Impact factor: 9.097

4.  Use of the Renal Angina Index in Determining Acute Kidney Injury.

Authors:  Ryo Matsuura; Nattachai Srisawat; Rolando Claure-Del Granado; Kent Doi; Teruhiko Yoshida; Masaomi Nangaku; Eisei Noiri
Journal:  Kidney Int Rep       Date:  2018-02-03

5.  Heart rate elevations during early sepsis predict death in fluid-resuscitated rats with fecal peritonitis.

Authors:  Alain Rudiger; Victor Jeger; Mattia Arrigo; Christian A Schaer; Florian F Hildenbrand; Margarete Arras; Burkhardt Seifert; Mervyn Singer; Gabriele Schoedon; Donat R Spahn; Dominique Bettex
Journal:  Intensive Care Med Exp       Date:  2018-08-20

6.  Response to different furosemide doses predicts AKI progression in ICU patients with elevated plasma NGAL levels.

Authors:  Ryo Matsuura; Yohei Komaru; Yoshihisa Miyamoto; Teruhiko Yoshida; Kohei Yoshimoto; Rei Isshiki; Kengo Mayumi; Tetsushi Yamashita; Yoshifumi Hamasaki; Masaomi Nangaku; Eisei Noiri; Naoto Morimura; Kent Doi
Journal:  Ann Intensive Care       Date:  2018-01-17       Impact factor: 6.925

7.  Landiolol in patients with septic shock resident in an intensive care unit (LANDI-SEP): study protocol for a randomized controlled trial.

Authors:  Martin Unger; Andrea Morelli; Mervyn Singer; Peter Radermacher; Sebastian Rehberg; Helmut Trimmel; Michael Joannidis; Gottfried Heinz; Vladimír Cerny; Pavel Dostál; Christian Siebers; Fabio Guarracino; Francesca Pratesi; Gianni Biancofiore; Massimo Girardis; Pavla Kadlecova; Olivier Bouvet; Michael Zörer; Barbara Grohmann-Izay; Kurt Krejcy; Christoph Klade; Günther Krumpl
Journal:  Trials       Date:  2018-11-19       Impact factor: 2.279

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.